ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Alternative Medicine by Palliative Care Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03260946
Recruitment Status : Recruiting
First Posted : August 24, 2017
Last Update Posted : August 24, 2017
Sponsor:
Information provided by (Responsible Party):
Hospices Civils de Lyon

August 22, 2017
August 24, 2017
August 24, 2017
July 11, 2017
July 11, 2018   (Final data collection date for primary outcome measure)
Complementary medicine use [ Time Frame: 15 minutes ]
The prevalence of complementary medicine use. Data collected using a questionnaire.
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
The Use of Alternative Medicine by Palliative Care Patients
The Use of Complementary Medicine in Palliative/Supportive Care Centres in Lyon, France

Palliative care centres in Lyon, France as well as the disclosure of Complementary and Alternative Medicine and conventional healthcare use to conventional and Complementary and Alternative Medicine practitioners respectively.

These aims will be achieved through the following objectives:

  1. Describe the prevalence of Complementary and Alternative Medicine practitioner and product use in the outpatient population of palliative care centres in Lyon, France
  2. Describe the characteristics of Complementary and Alternative Medicine users the outpatient population of palliative care centres in Lyon, France
  3. Estimate the Complementary and Alternative Medicine expenditure of the outpatient population of palliative care centres in Lyon, France
  4. Describe the rates of disclosure of both Complementary and Alternative Medicine and conventional health care to health professionals by the outpatient population of palliative care centres in Lyon, France
  5. Describe the reasons for disclosure or non-disclosure of both Complementary and Alternative Medicine and conventional health care to health professionals by the outpatient population of palliative care centres in Lyon, France
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Individuals with cancer receiving palliative or supportive care
  • Cancer
  • Terminal Cancer
Other: Complementary medicine use
The prevalence of complementary medicine use
Palliative/Supportive care
Individuals with cancer receiving palliative or supportive care
Intervention: Other: Complementary medicine use
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
300
Same as current
July 11, 2018
July 11, 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Patients accessing care from a palliative/supportive care centre in Lyon, France
  2. Can read and understand French
  3. Has been diagnosed with cancer

Exclusion Criteria:

  1. The primary health condition for which they are attending the centre is not cancer
  2. They are not able to read and understand French
Sexes Eligible for Study: All
18 Years and older   (Adult, Older Adult)
No
Contact: Marilène FILBET, Pr 0478861482 ext +33 marilene.filbet@chu-lyon.fr
France
 
 
NCT03260946
69HCL17_0217
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Hospices Civils de Lyon
Hospices Civils de Lyon
Not Provided
Not Provided
Hospices Civils de Lyon
August 2017